Literature DB >> 15038979

Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms.

Giorgio Minotti1, Stefania Recalcati, Pierantonio Menna, Emanuela Salvatorelli, Gianfranca Corna, Gaetano Cairo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15038979     DOI： 10.1016/S0076-6879(04)78025-8

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN： 0076-6879            Impact factor:   1.600


× No keyword cloud information.
  37 in total

Review 1.  Molecular control of vertebrate iron homeostasis by iron regulatory proteins.

Authors:  Michelle L Wallander; Elizabeth A Leibold; Richard S Eisenstein
Journal:  Biochim Biophys Acta       Date:  2006-05-17

2.  Poly(ADP-ribose) polymerase regulates myocardial calcium handling in doxorubicin-induced heart failure.

Authors:  Orsolya Szenczi; Péter Kemecsei; Max F J Holthuijsen; Natal A W van Riel; Ger J van der Vusse; Pál Pacher; Csaba Szabó; Márk Kollai; László Ligeti; Tamás Ivanics
Journal:  Biochem Pharmacol       Date:  2005-01-12       Impact factor: 5.858

3.  Doxorubicin pathways: pharmacodynamics and adverse effects.

Authors:  Caroline F Thorn; Connie Oshiro; Sharon Marsh; Tina Hernandez-Boussard; Howard McLeod; Teri E Klein; Russ B Altman
Journal:  Pharmacogenet Genomics       Date:  2011-07       Impact factor: 2.089

4.  THE ROLE OF PROTEIN CHAPERONES IN THE SURVIVAL FROM ANTHRACYCLINE-INDUCED OXIDATIVE STRESS IN SACCHAROMYCES CEREVISIAE.

Authors:  Jana S Miles; Samantha J Sojourner; Lahcen Jaafar; Aurellia Whitmore; Selina Darling-Reed; Hernan Flores-Rozas
Journal:  Int J Adv Res (Indore)       Date:  2018-03

Review 5.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release.

Authors:  Dmitry B Zorov; Magdalena Juhaszova; Steven J Sollott
Journal:  Physiol Rev       Date:  2014-07       Impact factor: 37.312

6.  Comparative effects of doxorubicin and a doxorubicin analog, 13-deoxy, 5-iminodoxorubicin (GPX-150), on human topoisomerase IIβ activity and cardiac function in a chronic rabbit model.

Authors:  Nicole E Frank; Barry J Cusack; Todd T Talley; Gerald M Walsh; Richard D Olson
Journal:  Invest New Drugs       Date:  2016-08-31       Impact factor: 3.850

Review 7.  Doxorubicin-Induced Cardiomyopathy in Children.

Authors:  Trevi R Mancilla; Brian Iskra; Gregory J Aune
Journal:  Compr Physiol       Date:  2019-06-12       Impact factor: 9.090

Review 8.  Hematopoietic Stem Cells: Normal Versus Malignant.

Authors:  Dustin Carroll; Daret K St Clair
Journal:  Antioxid Redox Signal       Date:  2017-12-20       Impact factor: 8.401

9.  Activation of the aryl hydrocarbon receptor by doxorubicin mediates cytoprotective effects in the heart.

Authors:  Maria Volkova; Monica Palmeri; Kerry S Russell; Raymond R Russell
Journal:  Cardiovasc Res       Date:  2011-01-13       Impact factor: 10.787

10.  Role of hypoxia-inducible factors in the dexrazoxane-mediated protection of cardiomyocytes from doxorubicin-induced toxicity.

Authors:  R D Spagnuolo; S Recalcati; L Tacchini; G Cairo
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.